Applications of kidney organoids derived from human pluripotent stem cells

키워드

참고문헌 (68)

1. Morizane R, "Nephron organoids derived from human pluripotent stem cells model kidney development and injury", Nat Biotechnol, 33, pp.1193~1200 (2015)[DOI]
2. Taguchi A, "Redefining the in vivo origin of metanephric nephron progenitors enables generation of complex kidney structures from pluripotent stem cells", Cell Stem Cell, 14, pp.53~67 (2014)[DOI]
3. Takasato M, "Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney", Nat Cell Biol, 16, pp.118~126 (2014)[DOI]
4. Takasato M, "Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis", Nature, 526, pp.564~568 (2015)[DOI]
5. Kim YK, "Gene-edited human kidney organoids reveal mechanisms of disease in podocyte development", Stem Cells, 35, pp.2366~2378 (2017)[DOI]
6. Peters DJ, "Autosomal dominant polycystic kidney disease: modification of disease progression", Lancet, 358, pp.1439~1444 (2001)[DOI]
7. Willey CJ, "Prevalence of autosomal dominant polycystic kidney disease in the European Union", Nephrol Dial Transplant, 32, pp.1356~1363 (2017)
8. Cruz NM, "Organoid cystogenesis reveals a critical role of microenvironment in human polycystic kidney disease", Nat Mater, 16, pp.1112~1119 (2017)[DOI]
9. Freedman BS, "Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids", Nat Commun, 6, pp.8715~ (2015)[DOI]
10. Freedman BS, "Modeling kidney disease with iPS cells", Biomark Insights, 10(Suppl 1), pp.153~169 (2015)
11. Romagnani P, "Organoids: modelling polycystic kidney disease", Nat Mater, 16, pp.1058~1059 (2017)[DOI]
12. Happe H, "Translational research in ADPKD: lessons from animal models", Nat Rev Nephrol, 10, pp.587~601 (2014)[DOI]
13. Carone FA, "Impaired tubulogenesis of cyst-derived cells from autosomal dominant polycystic kidneys", Kidney Int, 47, pp.861~868 (1995)[DOI]
14. Cruz NM, "CRISPR gene editing in the kidney", Am J Kidney Dis, 71, pp.874~883 (2018)[DOI]
15. De Vriese AS, "Differentiating primary, genetic, and secondary FSGS in adults: a clinicopathologic approach", J Am Soc Nephrol, 29, pp.759~774 (2018)
16. Devarajan P, "Towards a biological characterization of focal segmental glomerulosclerosis", Am J Kidney Dis, 39, pp.625~636 (2002)[DOI]
17. 강희경, "Loss of podocalyxin causes a novel syndromic type of congenital nephrotic syndrome", Experimental and Molecular Medicine, 49, pp.1~6 (2017), 생화학분자생물학회
18. Devuyst O, "Rare inherited kidney diseases: challenges, opportunities, and perspectives", Lancet, 383, pp.1844~1859 (2014)[DOI]
19. Tiong HY, "Drug-induced nephrotoxicity: clinical impact and preclinical in vitro models", Mol Pharm, 11, pp.1933~1948 (2014)[DOI]
20. Wilmer MJ, "Kidney-on-a-chip technology for drug-induced nephrotoxicity screening", Trends Biotechnol, 34, pp.156~170 (2016)[DOI]
21. Anzai N, "Integrated physiology of proximal tubular organic anion transport", Curr Opin Nephrol Hypertens, 14, pp.472~479 (2005)[DOI]
22. Morrissey KM, "Renal transporters in drug development", Annu Rev Pharmacol Toxicol, 53, pp.503~529 (2013)[DOI]
23. Li Y, "An in vitro method for the prediction of renal proximal tubular toxicity in humans", Toxicol Res, 2, pp.352~365 (2013)[DOI]
24. Su R, "Supervised prediction of drug-induced nephrotoxicity based on interleukin-6 and -8 expression levels", BMC Bioinformatics, 15(Suppl 16), pp.S16~ (2014)
25. Jenkinson SE, "The limitations of renal epithelial cell line HK-2 as a model of drug transporter expression and function in the proximal tubule", Pflugers Arch, 464, pp.601~611 (2012)[DOI]
26. Mutsaers HA, "Basolateral transport of the uraemic toxin p-Cresyl sulfate: role for organic anion transporters?", Nephrol Dial Transplant, 26, pp.4149~ (2011)[DOI]
27. Slusser A, "Cadherin expression, vectorial active transport, and metallothionein isoform 3 mediated EMT", MET responses in cultured primary and immortalized human proximal tubule cells, 2015, pp.10, e0120132~
28. Brown CD, "Characterisation of human tubular cell monolayers as a model of proximal tubular xenobiotic handling", Toxicol Appl Pharmacol, 233, pp.428~438 (2008)[DOI]
29. Lash LH, "Drug metabolism enzyme expression and activity in primary cultures of human proximal tubular cells", Toxicology, 244, pp.56~65 (2008)[DOI]
30. Van der Hauwaert C, "Isolation and characterization of a primary proximal tubular epithelial cell model from human kidney by CD10", CD13 double labeling, 2013, pp.8, e66750~
31. Li Y, "Identification of nephrotoxic compounds with embryonic stem-cellderived human renal proximal tubular-like cells", Mol Pharm, 11, pp.1982~1990 (2014)[DOI]
32. Narayanan K, "Human embryonic stem cells differentiate into functional renal proximal tubular-like cells", Kidney Int, 83, pp.593~603 (2013)[DOI]
33. Kandasamy K, "Prediction of drug-induced nephrotoxicity and injury mechanisms with human induced pluripotent stem cell-derived cells and machine learning methods", Sci Rep, 5, pp.12337~ (2015)[DOI]
34. Cukierman E, "Taking cell-matrix adhesions to the third dimension", Science, 294, pp.1708~1712 (2001)[DOI]
35. Cukierman E, "Cell interactions with three-dimensional matrices", Curr Opin Cell Biol, 14, pp.633~639 (2002)[DOI]
36. Geiger B, "Transmembrane crosstalk between the extracellular matrix: cytoskeleton crosstalk", Nat Rev Mol Cell Biol, 2, pp.793~805 (2001)[DOI]
37. Astashkina AI, "A 3-D organoid kidney culture model engineered for high-throughput nephrotoxicity assays", Biomaterials, 33, pp.4700~4711 (2012)[DOI]
38. Su R, "High-throughput imaging-based nephrotoxicity prediction for xenobiotics with diverse chemical structures", Arch Toxicol, 90, pp.2793~2808 (2016)[DOI]
39. Ramm S, "A high-throughput screening assay to identify kidney toxic compounds", Curr Protoc Toxicol, 69, pp.9~ (2016)
40. Czerniecki SM, "High-throughput screening enhances kidney organoid differentiation from human pluripotent stem cells and enables automated multidimensional phenotyping", Cell Stem Cell, 22, pp.929~940 (2018)[DOI]
41. Murphy SV, "3D bioprinting of tissues and organs", Nat Biotechnol, 32, pp.773~785 (2014)[DOI]
42. Homan KA, "Bioprinting of 3D convoluted renal proximal tubules on perfusable chips", Sci Rep, 6, pp.34845~ (2016)[DOI]
43. Osaki T, "Vascularized microfluidic organ-chips for drug screening, disease models and tissue engineering", Curr Opin Biotechnol, 52, pp.116~123 (2018)[DOI]
44. King S, "Design and characterization of a multicellular, three-dimensional (3D) tissue model of the human kidney proximal tubule", FASEB J, 29(1 Suppl), pp.LB426~ (2015)
45. Atala A, "Tissue-engineered autologous bladders for patients needing cystoplasty", Lancet, 367, pp.1241~1246 (2006)[DOI]
46. Chang JW, "Tissue-engineered tracheal reconstruction using three-dimensionally printed artificial tracheal graft: preliminary report", Artif Organs, 38, pp.E95~E105 (2014)[DOI]
47. Chuah JKC, "Stem cell-derived kidney cells and organoids: recent breakthroughs and emerging applications", Biotechnol Adv, 35, pp.150~167 (2017)[DOI]
48. Jha V, "Chronic kidney disease: global dimension and perspectives", Lancet, 382, pp.260~272 (2013)[DOI]
49. 진동찬, "Current characteristics of dialysis therapy in Korea: 2016 registry data focusing on diabetic patients", Kidney Research and Clinical Practice, 37(1), pp.20~29 (2018), 대한신장학회
50. 진동찬, "Lessons from 30 years’ data of Korean end-stage renal disease registry, 1985–2015", Kidney Research and Clinical Practice, 34(3), pp.132~139 (2015), 대한신장학회
51. Marcio G, "Chronic kidney disease and risk factors responsible for sudden cardiac death: a whiff of hope?", Kidney Research and Clinical Practice, 35(1), pp.3~9 (2016), 대한신장학회
52. 정혜윤, "Association of serum uric acid level with coronary artery stenosis severity in Korean end-stage renal disease patients", Kidney Research and Clinical Practice, 36(3), pp.282~289 (2017), 대한신장학회
53. 배은희, "Risk factors for in-hospital mortality in patients starting hemodialysis", Kidney Research and Clinical Practice, 34(3), pp.154~159 (2015), 대한신장학회
54. Imberti B, "Renal progenitors derived from human iPSCs engraft and restore function in a mouse model of acute kidney injury", Sci Rep, 5, pp.8826~ (2015)[DOI]
55. Sharmin S, "Human induced pluripotent stem cell-derived podocytes mature into vascularized glomeruli upon experimental transplantation", J Am Soc Nephrol, 27, pp.1778~1791 (2016)[DOI]
56. Toyohara T, "Cell therapy using human induced pluripotent stem cell-derived renal progenitors ameliorates acute kidney injury in mice", Stem Cells Transl Med, 4, pp.980~992 (2015)[DOI]
57. van den Berg CW, "Renal subcapsular transplantation of PSC-derived kidney organoids induces neo-vasculogenesis and significant glomerular and tubular maturation in vivo", Stem Cell Reports, 10, pp.751~765 (2018)[DOI]
58. Gonfiotti A, "The first tissue-engineered airway transplantation: 5-year follow-up results", Lancet, 383, pp.238~244 (2014)[DOI]
59. Macchiarini P, "Clinical transplantation of a tissue-engineered airway", Lancet, 372, pp.2023~2030 (2008)[DOI]
60. Song JJ, "Regeneration and experimental orthotopic transplantation of a bioengineered kidney", Nat Med, 19, pp.646~651 (2013)[DOI]
61. Bonandrini B, "Recellularization of well-preserved acellular kidney scaffold using embryonic stem cells", Tissue Eng Part A, 20, pp.1486~1498 (2014)[DOI]
62. Guan Y, "The effective bioengineering method of implantation decellularized renal extracellular matrix scaffolds", Oncotarget, 6, pp.36126~36138 (2015)
63. Caralt M, "Optimization and critical evaluation of decellularization strategies to develop renal extracellular matrix scaffolds as biological templates for organ engineering and transplantation", Am J Transplant, 15, pp.64~75 (2015)[DOI]
64. Hachisuka S, "Enhanced recellularization of renal extracellular matrix scaffold under negative pressure", Integr Mol Med, 2, pp.394~399 (2015)
65. Du C, "Functional kidney bioengineering with pluripotent stem-cell-derived renal progenitor cells and decellularized kidney scaffolds", Adv Healthc Mater, 5, pp.2080~2091 (2016)[DOI]
66. Sampaio FJ, "The pig kidney as an endourologic model: anatomic contribution", J Endourol, 12, pp.45~50 (1998)[DOI]
67. Wilm B, "Autologous cells for kidney bioengineering", Curr Transplant Rep, 3, pp.207~220 (2016)[DOI]
68. Morizane R, "Kidney organoids: a translational journey", Trends Mol Med, 23, pp.246~263 (2017)[DOI]

관련 논문AI추천